Home | Looking for something? Sign In | New here? Sign Up | Log out

Friday, January 7, 2011

Synthetic Proteins that Sustain Life Created

Friday, January 7, 2011
0 comments

Genetic Engineering & Biotechnology News
Quick Links
  Visit GEN on Twitter
 
GEN NEWS HIGHLIGHTS
Friday, January 7, 2011


Advertisement

SPONSORED LINK
Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc.
FREE summary, plus donation to GAVI, or ACS
Click Here! Receive FREE summary


Synthetic Proteins that Sustain Life Created
Proteins designed from artificial sequences rescued knockout bacterial strains.

Genetic Abnormalities Found in Pluripotent Stem Cell Lines
Analysis revealed the need to monitor such cell cultures often.

Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based Anticancer Drug Deal
Partnership provides Ziopharm with rights to UltraVector platform and two clinical-stage oncology candidates.


BG Medicine to Develop Heart Failure Test for Siemens
Galectin-3 diagnostic will be developed for Siemens' automated immunoassay platforms.

Pfizer Taps Sutro to Develop Peptide-Based Therapeutics
Sutro's protein-synthesis technology reportedly gets around hurdles associated with conventional methods.

Amgen Secures Option to Xencor's Dual-Targeting mAb for Autoimmune Diseases
Firm will wait for Phase II data before deciding whether to license the CD19/CD32 candidate.

EC Clears Novartis' Lucentis for Diabetic Macular Edema
Phase III trials showed that antibody improves visual acuity rather than just stabilizing disease.

Wellcome Trust Purchases OpGen's Optical Mapping System for Genome Sequence Assembly
Sanger Institute expects to initiate mapping of bacteria and parasites this month.

Dalton to Provide Aseptic Fill/Finish Services to AdeTherapeutics
Deal covers therapeutic candidates for inflammatory diseases and acute-care medicine.


You can view more news broken down into over 90 categories and updated daily.



Analysis & Insight
Analysis & Insight 2010 in Review: Biotechnology Highlights
Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is

Webinars
Available on Demand: Original Broadcast Date - December 16, 2010
Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays
Sponsored by: Agilent Technologies

In Case You Missed It:
If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives.


Application Note Library
More App Notes

Online Exclusives

BLOGBIOTECH:
Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs
POLL:
Do you think the Green Movement goes too far in its opposition of many new technologies?    More Polls



More at GEN
GEN Subscriber Tools



Subscription Center l Unsubscribe l Update Your Profile l About GEN

IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions.

Contact Us For:
Advertising   Editorial   Business and Partnership Opportunities


This email was sent by:
Genetic Engineering & Biotechnology News
140 Huguenot St.,
New Rochelle, NY 10801, USA
 

read more

GEN News Highlights - News of the Week

0 comments

Genetic Engineering & Biotechnology News
Quick Links
  Visit GEN on Twitter
 
HIGHLIGHTS OF THE WEEK
December 31, 2010 - January 6, 2011


Advertisement

SPONSORED LINK
Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc.
FREE summary, plus donation to GAVI, or ACS
Click Here! Receive FREE summary

January 06, 2011, 10:03 AM EST
Investigators Identify Prognostic Marker for Treating Hep C with Peg-Interferon and Ribavirin
Team expects to launch a test based on the IP-10 marker this year.
January 06, 2011, 09:40 AM EST
Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene Transfer
Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging.
January 06, 2011, 10:06 AM EST
CHO Genome Sequenced by BGI and GT Life Sciences
Next step is data analysis and interpretation of genetic regulation in cell proliferation.

January 06, 2011, 10:04 AM EST
Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon
Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'.
January 06, 2011, 08:08 AM EST
Symphogen Raises About $134M to Progress Clinical-Stage Antibodies
Firm claims fundraising is largest ever in Europe by private biotech business.
January 05, 2011, 09:57 AM EST
Rituximab Biosimilar to Be Developed by Spectrum and Viropro
Roche/Genentech's mAb therapeutic raked in $5.6 billion in 2009 sales, and patents start expiring in 2014.
January 05, 2011, 09:09 AM EST
Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M
It is hoped that the new client base in China will provide promising opportunities for Merck Millipore.
January 05, 2011, 08:53 AM EST
Beckman Coulter to Develop aNK Assay for Pivotal Trial of Transgene's NSCLC Drug
French company projects that Phase IIb/III study with TG4010 will start later this year.
January 04, 2011, 10:29 AM EST
Genetic Link for Depression Furthered by Analysis of 54 Studies
Results challenge an evaluation of 14 studies that contradicted the initial discovery of this association.
January 04, 2011, 09:55 AM EST
Pfizer Pays $14M to Expand RNA Partnership with Santaris Pharma
Pfizer is adding 10 more targets, which could draw $600 million in milestones.
January 03, 2011, 09:43 AM EST
Sigma-Aldrich Takes Over Cerilliant to Pad Analytical Chemistry Portfolio
Acquired firm has over 2,800 products related to reference standards and materials.


You can view more news broken down into over 90 categories and updated daily.


Analysis & Insight
Analysis & Insight 2010 in Review: Biotechnology Highlights
Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is

Article from GEN's January 1 Issue
Is Innovation Finally Beginning to Pay Off?
The success rate in 2010 can be chalked up to the focus on cutting-edge technologies.



Webinars
Available on Demand: Original Broadcast Date - December 16, 2010
Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays
Sponsored by: Agilent Technologies

In Case You Missed It:
If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives.


Application Note Library
More App Notes



Online Exclusives

BLOGBIOTECH:
Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs


More at GEN
GEN Subscriber Tools



Subscription Center l Unsubscribe l Update Your Profile l About GEN

IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions.

Contact Us For:
Advertising   Editorial   Business and Partnership Opportunities


This email was sent by:
Genetic Engineering & Biotechnology News
140 Huguenot St.,
New Rochelle, NY 10801, USA
 

read more

Thursday, January 6, 2011

CHO Genome Sequenced by BGI and GT Life Sciences

Thursday, January 6, 2011
0 comments

Genetic Engineering & Biotechnology News
Quick Links
  Visit GEN on Twitter
 
GEN NEWS HIGHLIGHTS
Thursday, January 6, 2011


Advertisement

SPONSORED LINK
Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc.
FREE summary, plus donation to GAVI, or ACS
Click Here! Receive FREE summary


CHO Genome Sequenced by BGI and GT Life Sciences
Next step is data analysis and interpretation of genetic regulation in cell proliferation.

Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon
Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'.

Symphogen Raises About $134M to Progress Clinical-Stage Antibodies
Firm claims fundraising is largest ever in Europe by private biotech business.


Investigators Identify Prognostic Marker for Treating Hep C with Peg-Interferon and Ribavirin
Team expects to launch a test based on the IP-10 marker this year.

Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene Transfer
Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging.

Cell Medica and Baylor's CAGT Ally to Commercialize EBV-CTL Cancer Therapy
Partners will develop commercial GMP process and hope to start Phase II/III study in 2012.

GSK Licenses Immutep's T-Cell Depleting Antibodies for Autoimmune Diseases
Firm hopes selective depletion of activated T cells will lead to longer-lasting, safer therapy.

Horizon and University of Washington Partner to Apply Gene Editing to IPSCs
$400,000 project aims to generate new X-Man cell lines and bioproduction reagents.

Receptos and Lilly Enter Agreement Focused on a GPCR Target
Receptos' technology will be used to find small molecule modulators.

Chiva Nabs Chinese Rights to Ligand's Hep B and HCC Candidates
Use of Ligand's HepDirect tech for the development of new candidates against hep B, hep C, and HCC part of deal.


You can view more news broken down into over 90 categories and updated daily.



Analysis & Insight
Analysis & Insight 2010 in Review: Biotechnology Highlights
Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is

Webinars
Available on Demand: Original Broadcast Date - December 16, 2010
Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays
Sponsored by: Agilent Technologies

In Case You Missed It:
If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives.


Application Note Library
More App Notes

Online Exclusives

BLOGBIOTECH:
Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs


More at GEN
GEN Subscriber Tools



Subscription Center l Unsubscribe l Update Your Profile l About GEN

IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions.

Contact Us For:
Advertising   Editorial   Business and Partnership Opportunities


This email was sent by:
Genetic Engineering & Biotechnology News
140 Huguenot St.,
New Rochelle, NY 10801, USA
 

read more
 

Popular Posts